Business
OS Therapies Announces Warrant Exercise Inducement & Exchange Offer
NEW YORK, June 24, 2025--OS Therapies Inc. (NYSE-A: OSTX) ("OS Therapies" or "the Company"), a clinical-stage immunotherapy and Antibody Drug Conjugate (ADC) biopharmaceutical company, today announced a warrant exercise inducement and exchange offer to holders of its five-year warrants with a current exercise price of $1.12 per share that were issued in connection with a PIPE financing transaction that had an initial closing date of December 31, 2024 (the "Old Warrants"). The Company is offering
About this update from Os Therapies Incorporated
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":1024,"height":512,"url":"https://media.zenfs.com/en/business-wire.com/1e787576edc0ce6ecb91847f9ca2b9e8"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/dPoTL9RGxZcBGmoQgb80nQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTQ4MDtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/1e787576edc0ce6ecb91847f9ca2b9e8","width":960,"height":480},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/iXXeH3MyVo6t9UpKGAlPWg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTIwNDg7aD0xMDI0O2NmPXdlYnA-/https://media.zenfs.com/en/business-wire.com/1e787576edc0ce6ecb91847f9ca2b9e8","width":1024,"height":512}},"lazy":false},{"type":"list","items":[{"val":[{"type":"text","content":"Current holders of five-year warrants with a current exercise price of $1.12 per share issued in connection with PIPE transaction initially closed on December 31, 2024 ("Old Warrants") offered opportunity to exercise Old Warrants now to receive new five-year warrants with an exercise price of $3.00 per share (the "New Warrants")","length":350,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Exercise of all Old Warrants would provide a maximum of ~$8 million in gross proceeds, $1.76 million of which has already been received by the Company, thereby extending cash runway into second half of 2026","length":206,"tagName":"p","attribs":{}}]}],"tagName":"ul","bulletedList":true,"length":556,"olType":false},{"type":"text","content":"NEW YORK, June 24, 2025--(BUSINESS WIRE)--OS Therapies Inc. (NYSE-A: OSTX) ("OS Therapies" or "the Company"), a clinical-stage immunotherapy and Antibody Drug Conjugate (ADC) biopharmaceutical company, today announced a warrant exercise inducement and exchange offer to holders of its five-year warrants with a current exercise price of $1.12 per share that were issued in connection with a PIPE financing transaction that had an initial closing date of December 31, 2024 (the "Old Warrants"). The Company is offering holders of Old Warrants the opportunity to exercise the Old Warrants now in consideration of the receipt of new five-year warrants to purchase a number of shares of common stock equal to the number of Old Warrants exercised with an exercise price of $3.00 per share, on subst...